Search

Showing "11155" results for ""

HIV drugs and heart attacks: what’s the real story?

Adherence: study shows protease inhibitors more forgiving of missed doses, even when treatment out of date

Danes find more evidence linking abacavir treatment with increased risk of heart attack

Tesamorelin safe and effective for fat accumulation in patients taking HIV treatment

New heat-stable ritonavir tablet approved in Europe

TB/HIV treatment literacy

Vision loss affecting one in ten Ugandan people with HIV

Less resistance with FTC than 3TC when combined with tenofovir

Higher viral load during early pregnancy, poor adherence, associated with increased risk of HIV infection for infants

HIV treatment responses in everyday care matching clinical trial levels

XDR TB emerging despite good adherence, due to sub-optimal treatment and bad infection control

Even very low levels of pre-existing resistance increase risk of efavirenz failure

Pregnancy rates rise in women after beginning ART

Detectable viral load in CSF risk associated with neurological problems in patients taking HIV treatment

Gay men’s risk of acquiring HIV is similar to the pre-HAART era despite widespread use of HAART

Preventing cervical cancer: good outcomes from screening programme for HIV-positive Zambian women

Goosby warns of need for long-term funding commitment for AIDS, says financial trades tax is 'interesting'

Risk factors for lung cancer in people with HIV: smoking vastly outweighs HIV

Receive the latest HIV research and conference news

Showing "11155" results for ""

HIV drugs and heart attacks: what’s the real story?

Adherence: study shows protease inhibitors more forgiving of missed doses, even when treatment out of date

Danes find more evidence linking abacavir treatment with increased risk of heart attack

Tesamorelin safe and effective for fat accumulation in patients taking HIV treatment

New heat-stable ritonavir tablet approved in Europe

TB/HIV treatment literacy

Vision loss affecting one in ten Ugandan people with HIV

Less resistance with FTC than 3TC when combined with tenofovir

Higher viral load during early pregnancy, poor adherence, associated with increased risk of HIV infection for infants

HIV treatment responses in everyday care matching clinical trial levels

XDR TB emerging despite good adherence, due to sub-optimal treatment and bad infection control

Even very low levels of pre-existing resistance increase risk of efavirenz failure

Pregnancy rates rise in women after beginning ART

Detectable viral load in CSF risk associated with neurological problems in patients taking HIV treatment

Gay men’s risk of acquiring HIV is similar to the pre-HAART era despite widespread use of HAART

Preventing cervical cancer: good outcomes from screening programme for HIV-positive Zambian women

Goosby warns of need for long-term funding commitment for AIDS, says financial trades tax is 'interesting'

Risk factors for lung cancer in people with HIV: smoking vastly outweighs HIV

Receive the latest HIV research and conference news